André Hoerning
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
André Hoerning has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Peter F. Hoyer
Clinic for Pediatrics II, Department of Pediatric Nephrology, Gastroenterology, Endocrinology, and Transplant Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
2 shared publicationsCarsten Müntjes
Clinic for Pediatrics III, Department of Pediatric Cardiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
1 shared publicationChristian Rehme
Department of Pediatrics II, Pediatric Nephrology, Gastroenterology, Endocrinology and Transplant Medicine, Children’s Hospital, University of Duisburg‐Essen, Essen
1 shared publicationElke Lainka
Clinic for Pediatrics II, Department of Pediatric Nephrology, Gastroenterology, Endocrinology, and Transplant Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
1 shared publicationFlorian Stehling
Clinic for Pediatrics III, Department of Pediatric Pulmonology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
1 shared publication- Halime Kalkavan
Department of Medical Oncology West German Cancer Center, University Hospital Essen Essen Germany
1 shared publication
Latest Publications
- 1 March 2014
- Published by Elsevier in The Journal of Pediatrics
- Vol. 164 (3) , 546-552.e2
Pulse Oximetry Is Insufficient for Timely Diagnosis of Hepatopulmonary Syndrome in Children with Liver Cirrhosis
- 1 March 2014
- Published by Elsevier in The Journal of Pediatrics
- Vol. 164 (3) , 546-552.e2
Pulse Oximetry Is Insufficient for Timely Diagnosis of Hepatopulmonary Syndrome in Children with Liver Cirrhosis
- 4 October 2011
- Published by Wiley in Pediatric Transplantation
- Vol. 15 (8) , 809-818
Quantitative real‐time ARMS‐qPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients
The presence of microchimerism in peripheral blood of solid organ transplant recipients has been postulated to be beneficial for allograft acceptance. Kinetics of donor cell trafficking and accumulation in pediatric allograft recipients are largely unknown. In this study, we implemented SNPs of the HVRs I and II of mitochondrial DNA to serve as molecular genetic markers to detect donor-specific cell chimerism after pediatric renal transplantation. Serial dilution of artificial chimeric DNA samples showed a linear correlation coefficient of R > 0.98 and a detection sensitivity of 0.01% with high reproducibility. Longitudinal semiquantitative analysis of donor-specific SNPs was then performed in peripheral blood mononuclear cells samples up to two yr post-transplant. Quantity of donor-specific cell chimerism in peripheral blood was highest in the early post-transplant period reaching values of ~10% after liver-kidney and 2.8% after renal transplantation. From one wk after transplantation, renal transplant patients exhibited an amount of donor-specific mtDNA ranging from 0.01% to 0.1%. We developed a highly accurate, sensitive, and rapid real-time quantitative PCR method using sequence-specific primers and fluorescent hydrolysis probes for the detection of at least 0.01% donor-specific cells in the recipient's peripheral blood after renal transplantation.
- 4 October 2011
- Published by Wiley in Pediatric Transplantation
- Vol. 15 (8) , 809-818
Quantitative real‐time ARMS‐qPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients
The presence of microchimerism in peripheral blood of solid organ transplant recipients has been postulated to be beneficial for allograft acceptance. Kinetics of donor cell trafficking and accumulation in pediatric allograft recipients are largely unknown. In this study, we implemented SNPs of the HVRs I and II of mitochondrial DNA to serve as molecular genetic markers to detect donor-specific cell chimerism after pediatric renal transplantation. Serial dilution of artificial chimeric DNA samples showed a linear correlation coefficient of R > 0.98 and a detection sensitivity of 0.01% with high reproducibility. Longitudinal semiquantitative analysis of donor-specific SNPs was then performed in peripheral blood mononuclear cells samples up to two yr post-transplant. Quantity of donor-specific cell chimerism in peripheral blood was highest in the early post-transplant period reaching values of ~10% after liver-kidney and 2.8% after renal transplantation. From one wk after transplantation, renal transplant patients exhibited an amount of donor-specific mtDNA ranging from 0.01% to 0.1%. We developed a highly accurate, sensitive, and rapid real-time quantitative PCR method using sequence-specific primers and fluorescent hydrolysis probes for the detection of at least 0.01% donor-specific cells in the recipient's peripheral blood after renal transplantation.